NO953647L - Veterinær-medikament med forlenget frigjöring - Google Patents

Veterinær-medikament med forlenget frigjöring

Info

Publication number
NO953647L
NO953647L NO953647A NO953647A NO953647L NO 953647 L NO953647 L NO 953647L NO 953647 A NO953647 A NO 953647A NO 953647 A NO953647 A NO 953647A NO 953647 L NO953647 L NO 953647L
Authority
NO
Norway
Prior art keywords
extended release
gelling agent
veterinary drug
fatty acid
oily vehicle
Prior art date
Application number
NO953647A
Other languages
English (en)
Other versions
NO953647D0 (no
Inventor
Alan Patterson
Drew Holmes
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of NO953647D0 publication Critical patent/NO953647D0/no
Publication of NO953647L publication Critical patent/NO953647L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Veterinær-blanding med vedvarende frigjøring for intramuskulær og subkutan tilferesl omfattende "Tylosin" og et oljeaktig bærermateriale inneholdende et geldannende middel, hvor det geldannende middel kan være et aluminium- salt av en fettsyre såsom stearinsyre og det oljeaktige bærermateriale kan være en lav-viskositets polyol-diester av en kortkjedet naturlig avledet fettsyre såsom propylen- glykol-dikaprylat/dikaprat.
NO953647A 1993-03-24 1995-09-15 Veterinær-medikament med forlenget frigjöring NO953647L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition
PCT/GB1994/000578 WO1994021267A1 (en) 1993-03-24 1994-03-22 Tylosin containing sustained release veterinary compositions

Publications (2)

Publication Number Publication Date
NO953647D0 NO953647D0 (no) 1995-09-15
NO953647L true NO953647L (no) 1995-11-22

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953647A NO953647L (no) 1993-03-24 1995-09-15 Veterinær-medikament med forlenget frigjöring

Country Status (23)

Country Link
EP (1) EP0689444B1 (no)
JP (1) JPH08508032A (no)
KR (1) KR100283369B1 (no)
CN (1) CN1096268C (no)
AT (1) ATE181834T1 (no)
AU (1) AU669435B2 (no)
BG (1) BG62352B1 (no)
BR (1) BR9406202A (no)
CA (1) CA2158662C (no)
DE (1) DE69419408T2 (no)
DK (1) DK0689444T3 (no)
ES (1) ES2135568T3 (no)
FI (1) FI954447A (no)
GB (1) GB9306106D0 (no)
GR (1) GR3031293T3 (no)
HU (1) HUT73424A (no)
IL (1) IL109053A (no)
NO (1) NO953647L (no)
NZ (1) NZ262756A (no)
PE (1) PE7595A1 (no)
PL (1) PL175127B1 (no)
RO (1) RO114738B1 (no)
WO (1) WO1994021267A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
CN116407505A (zh) * 2023-03-28 2023-07-11 青岛康地恩动物药业有限公司 一种高生物利用度泰万菌素干混悬剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
ATE66600T1 (de) * 1986-03-10 1991-09-15 American Cyanamid Co Verfahren zur herstellung einer bolusformulierung mit verzoegerter freisetzung.

Also Published As

Publication number Publication date
IL109053A0 (en) 1994-06-24
HU9502700D0 (en) 1995-11-28
PL310804A1 (en) 1996-01-08
CN1096268C (zh) 2002-12-18
FI954447A (fi) 1995-11-15
BR9406202A (pt) 1995-12-12
WO1994021267A1 (en) 1994-09-29
EP0689444B1 (en) 1999-07-07
KR960700732A (ko) 1996-02-24
DE69419408D1 (de) 1999-08-12
GB9306106D0 (en) 1993-05-12
KR100283369B1 (ko) 2001-03-02
NO953647D0 (no) 1995-09-15
ATE181834T1 (de) 1999-07-15
PL175127B1 (pl) 1998-11-30
JPH08508032A (ja) 1996-08-27
CA2158662C (en) 2009-06-30
CN1123525A (zh) 1996-05-29
EP0689444A1 (en) 1996-01-03
FI954447A0 (fi) 1995-09-20
HUT73424A (en) 1996-07-29
GR3031293T3 (en) 1999-12-31
BG100078A (bg) 1996-07-31
AU669435B2 (en) 1996-06-06
BG62352B1 (bg) 1999-09-30
IL109053A (en) 1999-09-22
DE69419408T2 (de) 1999-10-28
PE7595A1 (es) 1995-04-25
DK0689444T3 (da) 1999-11-22
AU6262194A (en) 1994-10-11
NZ262756A (en) 1997-06-24
RO114738B1 (ro) 1999-07-30
ES2135568T3 (es) 1999-11-01
CA2158662A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
DE69332222D1 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
FI92014C (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
NZ512287A (en) Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
BRPI0416590A (pt) excipientes em veìculos de distribuição de fármacos
PT659073E (pt) Matrizes polimericas biodegradaveis para entrega sustentada de agentes anestesicos locais
IL173441A (en) Long-release injection of aripiprazole and use of a mixture of aripiprazole on an injection device
EP0671162A3 (en) Amphoteric compositions and polymer forms of alpha-hydroxy acids, and their therapeutic use.
ATE220894T1 (de) Zusammensetzung für lokale freigabe von zytostatika
PE20050494A1 (es) Excipientes en vehiculos de suministro de farmacos
KR880009639A (ko) 서방성 매트릭스 제형
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
NO953647D0 (no) Veterinær-medikament med forlenget frigjöring
TR199902748T2 (xx) Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
WO2001049117A3 (en) An anti-viral lotion composition and a lotioned tissue product
WO1998033478A3 (en) Rna- and dna-based active agents in nanoparticles
BR9814090A (pt) Composição de drogas rapidamente solúvel
TH18460EX (th) สารผสมทางสัตวแพทย์ ที่ปลดปล่อยแบบถูกหน่วงเหนี่ยวที่มีไทลอซิน
MY109207A (en) Subcutaneous implants based on nomegestrol derivatives
CO4520277A1 (es) Nueva composicion terapeutica inyectable analgesica que con- tiene nimesulide y procedimiento de fabricacion de la misma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application